Regulatoriskt pressmeddelande

Spotlight Stock Market: Welcome back Redsense

"We had a very good cooperation and a rewarding relationship with Spotlight during the time we were listed on their marketplace. Spotlight gave us invaluable support in regulatory issues and market communication, which gives us at Redsense time to focus on what we do best, namely to conduct our business and demonstrate continued growth." Patrik Byhmer, CEO of Redsense Medical.

Redsense's vision is to save lives by detecting blood loss.Their solution is specifically designed to detect blood leakage and it is patented as a method of detecting blood loss from the human body, not just for hemodialysis.

Spotlight are happy for the confidence and are looking forward to support the company in their continuous development.

"We are happy and proud to once again have gained the confidence to act as the trading venue for Redsense's shares. It shows that we have a product and an offer that is valuable to our customers." Says Peter Gönczi, CEO at Spotlight